Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The California STEM Reporter.
Press releases published on June 13, 2025

Flow Cytometry Market Hits US$10.3B by 2032: Why Every Lab Needs a FACS Flow Cytometer?
Delray Beach, FL, June 13, 2025 (GLOBE NEWSWIRE) -- Ever wondered how scientists peek inside our cells, analyzing their secrets to diagnose diseases or develop life-saving therapies? It's all thanks to flow cytometry, a dynamic field transforming …

Rose Hill Apothecary Executes First Major International Export Deal, Supplying Research-Grade Psilocybin to Brazil
RUNAWAY BAY, Jamaica, June 13, 2025 (GLOBE NEWSWIRE) -- Rose Hill Apothecary (“The Company” or “Rose Hill”), a global leader in the research and intellectual property of premium psilocybin products, today announced the successful execution of its first …

Tiziana Life Sciences to Present at the Bio International Convention
NEW YORK, June 13, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a …

Introducing Surfshark Everlink: patented self-healing VPN infrastructure for stable VPN protection
Surfshark, a leading provider of VPN services, unveils Surfshark Everlink, an industry-first patented (patents: US11190491B1, US20240080302A1) technology designed to deliver greater VPN connection stability. Surfshark Everlink is a supporting, self-healing …

Game Pill’s HANGRY™ to Be Showcased with Live Demos at Pixel Power Play during Toronto Games Week
TORONTO, June 13, 2025 (GLOBE NEWSWIRE) -- Game Pill is thrilled to announce that its snack‑‘n‑slash RPG, HANGRY, will be available for live demonstration at Power Pixel Play, a new Toronto gaming event hosted by Toronto Community Meetup Powered By Twitch …

Medera and Novoheart Presented Breakthroughs in Human mini-Heart Platforms and Gene Therapy at ISSCR 2025
Showcased 7 presentations at ISSCR 2025, including a featured oral presentation on first-in-human gene therapy for heart failure, powered by their proprietary human mini-Heart technology. FDA-backed human-based screening platform recognized as an animal- …

Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SOUTH SAN FRANCISCO, Calif., June 13, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”, “Company”), a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and …

Panavance Therapeutics Announces Promising Misetionamide (GP-2250) Phase 1 Clinical Trial Interim Findings in Pancreatic Cancer at BIO 2025
Interim analysis shows misetionamide is very well tolerated in combination with gemcitabine; rates of confirmed response, stable disease, and progression-free survival compare favorably with gemcitabine monotherapy BERWYN, PA, June 13, 2025 (GLOBE NEWSWIRE …

Grace Therapeutics to Participate in the 2025 BIO International Conference
PRINCETON, N.J., June 13, 2025 (GLOBE NEWSWIRE) -- Grace Therapeutics, Inc. (Nasdaq: GRCE) (Grace Therapeutics or the Company), a late-stage, biopharma company advancing GTx-104, a clinical-stage, novel, injectable formulation of nimodipine being developed …

Processa Pharmaceuticals to Engage Potential Partners and Investors at BIO International Convention 2025
HANOVER, Md., June 13, 2025 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA), a clinical-stage pharmaceutical company developing Next Generation Cancer (NGC) therapies, today announced that members of its executive leadership team will …

June 2025 Letter to Shareholders of Nvni Group Limited
~ Building on a Strong Foundation through Operational Progress and Strategic Initiatives ~ NEW YORK, June 13, 2025 (GLOBE NEWSWIRE) -- Nuvini Group Limited (Nasdaq: NVNI) (“Nuvini” or the “Company”), a leading acquirer of private B2B SaaS companies in …

Official Announcement: Legal Statement on Trademark and App Name by RBH
San Diego, USA, June 13, 2025 (GLOBE NEWSWIRE) -- Today, RBH Infinity Exchange has issued a legal statement regarding its trademark and app name. The full text is as follows: This exchange and all its operations, services, products, and visual identifiers …

ALL4 Mining Launches User-Friendly Free Cloud Mining Platform to Support Cryptocurrency Enthusiasts Worldwide
Buffalo, NY, June 13, 2025 (GLOBE NEWSWIRE) -- ALL4 Mining, a cloud mining platform founded in 2019, has announced the global expansion of its mining services, aiming to make cryptocurrency investment more accessible to both new and existing investors. …

Sensei Biotherapeutics Announces 1-for-20 Reverse Stock Split
BOSTON, June 13, 2025 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage biotechnology company focused on the discovery and development of next-generation therapeutics for cancer patients, today announced that it will …

Altimmune Announces Multiple Presentations at Upcoming American Diabetes Association’s Scientific Sessions
GAITHERSBURG, Md., June 13, 2025 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company developing novel peptide-based therapeutics for liver and cardiometabolic diseases, today announced an oral presentation and …

reAlpha Expands Homebuying Platform into Texas, Marking First Step in National Realty Rollout
DUBLIN, Ohio, June 13, 2025 (GLOBE NEWSWIRE) -- reAlpha Tech Corp. (Nasdaq: AIRE) (“reAlpha” or the “Company”), an AI-powered real estate technology company, today announced the expansion of its platform into Texas1 with the launch of real estate brokerage …

New Wave Announces Investment in Cartwheel Robotics, an Advanced Robotics Company Seeking to Build Humanoids for Humans
Vancouver, BC, June 13, 2025 (GLOBE NEWSWIRE) -- New Wave Holdings Corp. (“New Wave” or the “Company”) (CSE:NWAI, FWB:0XM0, OTCPK:TRMNF) is pleased to announce that it has made a strategic investment of US$150,000 into Cartwheel Robotics Inc. (“Cartwheel …

AccuStem Sciences, Inc. Announces Chairman Purchase of Shares
LONDON, June 13, 2025 (GLOBE NEWSWIRE) -- AccuStem Sciences, Inc. (OTCQB: ACUT), a clinical stage diagnostics company dedicated to improving outcomes for patients with cancer, announced that its Chairman of the Board, Mr. Gabriele Cerrone, has notified the …

Arvinas Presents Preclinical Data for PROTAC BCL6 Degrader, ARV-393, at the European Hematology Association 2025 Congress
– ARV-393 demonstrated significant single-agent activity in models of nodal T-follicular helper cell lymphoma, angioimmunoblastic-type (also known as AITL) and transformed follicular lymphoma – – In combination with small molecule inhibitors, ARV-393 …

ORLADEYO® (berotralstat) Approved in Colombia
RESEARCH TRIANGLE PARK, N.C., June 13, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the National Institute of Drug and Food Surveillance (INVIMA) in Colombia has granted approval for oral, once-daily ORLADEYO …